Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen Ling Gu Ben immune granules
- Development stage
- Unknown
- Lead developer
- China Academy of Chinese Medical Sciences
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shen Ling Gu Ben immune granules is a Traditional Chinese Medicine (TCM) formulation developed by the China Academy of Chinese Medical Sciences. It is primarily investigated as an adjunctive therapy for HIV/AIDS patients who exhibit an inadequate immune response (poor CD4+ T-cell recovery) despite receiving stable combined antiretroviral therapy (cART/HAART). The formulation is designed to strengthen the spleen and consolidate the root (Shen Ling Gu Ben), a concept in TCM aimed at enhancing the body's immune function and overall constitution. Clinical studies, such as ChiCTR1800015290, evaluate its efficacy in promoting immune reconstitution and reducing chronic inflammation in HIV-infected individuals.
- Other names
- Shenling Guben granulesShenling Guben immune granules
Beyond the preview
Go deeper on Shen Ling Gu Ben immune granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shen Ling Gu Ben immune granules.